ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Adagene Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026
$2.29+0.23 (+11.17%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
32.5%
19M of 59M shares
Institutional holders
36
17 new, 5 sold out
Net institutional buying
16M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $162.26K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| HAN 2020 Irrevocable Trust | 9,390,439 | 11.20% | 13D (active) amendment | Jun 5, 2026 |
| Janus Henderson Group PLC | 6,666,666 | 10.10% | 13G (passive) | Apr 30, 2026 |
| Smith Vincent C | 5,095,351 | 8.70% | 13G (passive) amendment | Dec 31, 2025 |
| FIL Limited | 4,093,498 | 7.80% | 13G (passive) amendment | Dec 31, 2024 |
| OT Management, LLC | 3,567,653 | 8.10% | 13G (passive) amendment | Sep 6, 2024 |
| OT Healthcare Fund I, LLC | 3,277,814 | 5.90% | 13G (passive) | Sep 6, 2024 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 3,037,500 | 5.50% | 13G (passive) amendment | Dec 31, 2024 |
| Chernett Jorey | 2,389,060 | 5.10% | 13G (passive) | Mar 16, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ADAG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 6,666,666 | 11.26% | $28.10M | New | 0.01% |
| Siren, L.L.C. | 2,666,666 | 4.50% | $11.20M | New | 0.23% |
| Deerfield Management Company, L.P. (Series C) | 2,666,666 | 4.50% | $11.20M | New | 0.12% |
| Ameriprise Financial Inc | 1,716,711 | 2.90% | $7.21M | +1,108,808 | 0.00% |
| HSG Holding Ltd | 1,343,364 | 2.27% | $5.64M | – | 0.45% |
| Squadron Capital Management LLC | 1,250,000 | 2.11% | $5.25M | New | 1.63% |
| Dauntless Investment Group, LLC | 537,230 | 0.91% | $2.26M | +502,455 | 1.77% |
| Citadel Advisors LLC | 506,934 | 0.86% | $2.13M | New | 0.00% |
| Exome Asset Management LLC | 488,293 | 0.82% | $2.05M | −248,552 | 1.27% |
| Birchview Capital, LP | 240,000 | 0.41% | $1.01M | New | 0.47% |
| Moneta Group Investment Advisors LLC | 200,000 | 0.34% | $840.00K | New | 0.01% |
| Pathstone Holdings, LLC | 199,610 | 0.34% | $838.36K | New | 0.00% |
| Renaissance Technologies LLC | 146,500 | 0.25% | $615.30K | +111,967 | 0.00% |
| UBS Group AG | 124,063 | 0.21% | $521.07K | +120,061 | 0.00% |
| Goldman Sachs Group Inc | 105,598 | 0.18% | $443.51K | New | 0.00% |
| Quadrature Capital Ltd | 80,487 | 0.14% | $338.05K | +68,870 | 0.00% |
| Marshall Wace, Llp | 69,100 | 0.12% | $290.22K | New | 0.00% |
| Invesco Ltd. | 42,945 | 0.07% | $180.37K | −4,179 | 0.00% |
| SmartHarvest Portfolios, LLC | 41,694 | 0.07% | $175.12K | +1,382 | 0.06% |
| Kamunting Street Capital Management, L.P. | 38,070 | 0.06% | $160.00K | – | 0.09% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 36 | 19M | 32.5% | 17 / 10 | 6 / 5 | 17M | 0M |
| Q1 2026 | 25 | 3M | 5.6% | 11 / 3 | 6 / 3 | 1M | 1M |
| Q4 2025 | 17 | 3M | 5.2% | 4 / 4 | 3 / 4 | 1M | 4M |
| Q3 2025 | 17 | 6M | 9.7% | 3 / 2 | 6 / 1 | 0M | 0M |
| Q2 2025 | 15 | 6M | 10.3% | 3 / 3 | 3 / 2 | 0M | 2M |
| Q1 2025 | 14 | 8M | 12.9% | 2 / 1 | 6 / 3 | 0M | 3M |
| Q4 2024 | 15 | 10M | 17.6% | 4 / 5 | 1 / 1 | 4M | 1M |
| Q3 2024 | 13 | 11M | 19.3% | 1 / 2 | 3 / 2 | 0M | 0M |
| Q2 2024 | 14 | 11M | 18.9% | 2 / 1 | 5 / 5 | 0M | 1M |
| Q1 2024 | 17 | 12M | 21.1% | 6 / 3 | 2 / 0 | 5M | 0M |
| Q4 2023 | 11 | 7M | 12.3% | 2 / 1 | 1 / 1 | 4M | 1M |
| Q3 2023 | 10 | 4M | 6.9% | 1 / 2 | 1 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ADAG | Value | % of fund | As of |
|---|---|---|---|---|---|
| Invesco Golden Dragon China ETF | 42,285 | 0.07% | $158.57K | 0.16% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 10,309 | 0.02% | $40.93K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Man Kin Tam | Chief Financial Officer, Director | 12,000 | 0.02% | Sep 25, 2026 |
| Peter Luo | Chief Executive Officer, Director | 194,556 | 0.33% | Sep 17, 2026 |
| Mickael Yannick Chane-Du | Chief Strategy Officer | 467,525 | 0.79% | Mar 18, 2026 |
| Qinghai Zhao | Chief Manufacturing Officer | 37,500 | 0.06% | Mar 18, 2026 |
| Chunfang Gu | Executive Director of Finance | 7,045 | 0.01% | Mar 18, 2026 |
| Ling Zhou | ED of Human Resources | 2,969 | 0.01% | Mar 18, 2026 |
| Cuong V. Do | Director | 2,000 | 0.00% | Aug 18, 2026 |
| Andy Yiu Leung Cheung | Director | – | – | Aug 17, 2026 |
| Li Zhu | Director | – | – | Aug 17, 2026 |
| Ulf Grawunder | Director | 25,000 | 0.04% | Aug 14, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Man Kin Tam Chief Financial Officer, Director | Sep 23, 2026 | Buy | +2,000 | $3.00 | $6.00K | 12,000 |
| Peter Luo Chief Executive Officer, Director | Sep 16, 2026 | Buy | +20,290 | $3.15 | $63.91K | 88,535 |
| Cuong V. Do Director | Aug 14, 2026 | Buy | +2,000 | $3.75 | $7.50K | 2,000 |
| Peter Luo Chief Executive Officer, Director | Aug 5, 2026 | Buy | +279 | $3.65 | $1.02K | 68,245 |
| Peter Luo Chief Executive Officer, Director | Aug 4, 2026 | Buy | +22,966 | $3.65 | $83.83K | 67,966 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Inc. Adagene Officer | Aug 20, 2026 | 131,000 | $517.45K | Aug 21, 2026 | VESTING OF OPTIONS GRANTED PURSUANT TO ISSUER ESOP PLAN |
| Chunfang Gu Officer | Aug 19, 2026 | 131,000 | $517.45K | Aug 20, 2026 | VESTING OF OPTIONS GRANTED PURSUANT TO ISSUER ESOP PLAN |